Case | Age (years) | Gender | Transplant indication and type | Time to onset (days post-transplantation) | Diagnostic modality | Pulmonary functiona | Treatment | Other complications | Post-transplantation survival (days) | |
---|---|---|---|---|---|---|---|---|---|---|
 |  |  |  |  |  | FEV1 | FVC |  |  |  |
1 | 49 | Female | CHD with severe PH; HLT | 58 | TBB | na | na | Antibacterials Corticosteroids | Grade A1B0 acute rejection; Citrobacter freundii isolated from blood, BAL and urine | 118 |
2 | 26 | Male | CF; BLT | 299 | SLB | 54% | 79% | Antibacterials Corticosteroids | Candida albicans and Stenotrophomonas maltophilia isolated from blood; MSSA and mucoid Pseudomonas aeruginosa isolated from BAL | 344 |
3 | 41 | Female | Fibrotic NSIP; SLT (left) | 56 | TBB autopsy | 97% | 88% | Antibacterials Corticosteroids | Persistent poor graft function from the time of transplant; Grade A2B0 acute rejection (previous TBB) | 278 |
4 | 34 | Female | Bleomycin-related PF; BLT | 2,572 | TBB | 70% | 72% | Corticosteroids Antibacterials | Multi-drug-resistant S. maltophilia isolated from BAL; breast carcinoma metastatic to lungs | 2,793 |
5 | 71 | Female | IPF; SLT (right) | 1,354 | TBB | 63% | 74% | Corticosteroids Antibacterials | Onset preceded by symptomatic GER episode | 1,514 |
6 | 23 | Male | CF; BLT | 804 | TBB | 49% | 49% | Corticosteroids Antibacterials | URI symptoms and dyspnoea noted for 4 weeks prior to diagnosis | 1,476 |